C089-0471 Screening compound: ethyl 4-(4-{[(4-methoxyphenyl)carbamoyl]methyl}-3-[3-(4-methylpiperazin-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

C089-0471 Screening compound: ethyl 4-(4-{[(4-methoxyphenyl)carbamoyl]methyl}-3-[3-(4-methylpiperazin-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate
C089-0471 Screening compound: ethyl 4-(4-{[(4-methoxyphenyl)carbamoyl]methyl}-3-[3-(4-methylpiperazin-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound C089-0471
ethyl 4-(4-{[(4-methoxyphenyl)carbamoyl]methyl}-3-[3-(4-methylpiperazin-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C089-0471

Molecular Formula

C29H37N5O5S (C29 H37 N5 O5 S)

Compound Name

ethyl 4-(4-{[(4-methoxyphenyl)carbamoyl]methyl}-3-[3-(4-methylpiperazin-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

IUPAC name

ethyl 4-(4-{[(4-methoxyphenyl)carbamoyl]methyl}-3-[3-(4-methylpiperazin-1-yl)propyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

SMILES

CCOC(c(cc1)ccc1N(C(C(CC(Nc(cc1)ccc1OC)=O)N1CCCN2CCN(C)CC2)=O)C1=S)=O

InChI

InChI=1S/C29H37N5O5S/c1-4-39-28(37)21-6-10-23(11-7-21)34-27(36)25(20-26(35)30-22-8-12-24(38-3)13-9-22)33(29(34)40)15-5-14-32-18-16-31(2)17-19-32/h6-13,25H,4-5,14-20H2,1-3H3,(H,30,35)/t25-/m1/s1

InChI Key

OLNUPTAWHOXURS-RUZDIDTESA-N

MDL Number (MFCD)

MFCD14718492

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

567.71

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.429

Distribution Coefficient, logD

1.615

Water Solubility, LogSw

-2.81

Polar Surface Area

77.132

Acid Dissociation Constant (pKa)

11.86

Base Dissociation Constant (pKb)

8.14

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.80

C089-0471 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with C089-0471 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C089-0471?
Check Price and Availability of C089-0471, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C089-0471 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C089-0471
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C089-0471
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C089-0471 available by request